Aleafia Health
Aleafia Health Inc. is an integrated cannabis health and wellness company based in Concord, Canada. It produces a diverse range of products, including dried flower, pre-rolls, oil drops, capsules, and oral sprays, marketed under the Emblem and Symbl brands. The company operates a national network of 25 medical cannabis clinics, having served over 60,000 patients, and focuses on providing standardized, pesticide-free cannabis for those in need. Aleafia Health emphasizes evidence-based treatment by assisting physicians in making informed recommendations backed by historical data. The company also has three cannabis cultivation facilities, one of which is fully operational, contributing to its innovative research and development efforts in the cannabis sector.
Emblem
Acquisition in 2018
Emblem is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). Led by a team of cannabis experts and former health care and pharma executives, it has three distinct verticals – cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem trades under the ticker symbol “EMC” on TSX Venture Exchange.
Canabo Medical
Acquisition in 2018
Canabo wholly owns and operates Cannabinoid Medical Clinic (CMC), Canada’s largest referral-only clinic for medical cannabis. After opening in 2014, Canabo now has ten locations including Toronto, Barrie, Ottawa, Hamilton, Halifax, St. John’s and Edmonton, with a number of additional clinics opening in Alberta, New Brunswick and Ontario in 2016. CMC has over 40 physicians working in our clinics. We are a physician referral-only medical clinic. They work closely with both patients and physicians to address the need for cannabinoid therapy. The majority of their patients visit us for symptoms related to chronic pain, cancer, epilepsy, arthritis, anxiety, and MS. These patients have often tried multiple first and second line therapies with variable success, and have ongoing symptoms that cause significant distress and functional burden.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.